Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Human psychopharmacology

• Publication date

  2016-09-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/hup.2547PMID 27650406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Columbia-Suicide Severity Rating Scale

  2016cited by this paper
• Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials

  2015cited by this paper
• Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.

  2015influential reference
• Validation of the yale-brown obsessive compulsive scale modified for binge eating.

  2015cited by this paper
• The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys.

  2013cited by this paper
• A Longitudinal Study

  2013cited by this paper
• Binge Eating Disorder

  2013cited by this paper
• Amphetamine, past and present – a pharmacological and clinical perspective

  2013cited by this paper
• ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults

  2013cited by this paper
• ADHD drugs and serious cardiovascular events in children and young adults.

  2011influential reference
• Columbia-Suicide Severity Rating Scale (C-SSRS)

  2011influential reference
• Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder

  2010cited by this paper
• Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorder.

  2010cited by this paper
• Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study.

  2007cited by this paper
• Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial.

  2007cited by this paper
• Reliability of the Eating Disorder Examination-Questionnaire in patients with binge eating disorder.

  2006cited by this paper
• Applied Longitudinal Analysis

  2005cited by this paper
• EFFICACY AND SAFETY OF

  2004cited by this paper
• Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trial.

  2003cited by this paper
• Development and validation of the food-craving inventory.

  2002influential reference
• Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial.

  1998cited by this paper
• Conners' rating scales-revised : technical manual

  1997influential reference
• Assessment of eating disorders: interview or self-report questionnaire?

  1994cited by this paper
• The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

  1993influential reference
• Some conceptual and statistical issues in analysis of longitudinal psychiatric data. Application to the NIMH treatment of Depression Collaborative Research Program dataset.

  1993cited by this paper
• Oxytetracycline in the treatment of ocular rosacea: a double-blind trial.

  1982cited by this paper
• Department of Health, Education, and Welfare

  1974cited by this paper

• Multidimensional Evaluation of Lisdexamfetamine: Pharmacology, Therapeutic Use, Toxicity and Forensic Implications

  2025cites this paper
• Consider co-occurring conditions when selecting pharmacological treatment options for binge eating disorder

  2025cites this paper
• Pharmacotherapies for Binge Eating Disorder: Systematic Review and Network Meta‐Analysis

  2025cites this paper
• Effect of amphetamines on blood pressure.

  2025cites this paper
• Efficacy of opioid antagonist in patients with binge eating behavior: A systemic review and meta-analysis.

  2025cites this paper
• Understanding the Effects of Combined Lisdexamfetamine and Cognitive Behavior Therapy for Adults With Binge Eating Disorder.

  2025cites this paper
• Efficacy, Safety and Tolerability of Lisdexamfetamine Dimesylate Treatment Compared With Placebo in Adults With Binge-Eating Disorder: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

  2025cites this paper
• Recent developments in treatments for eating disorders.

  2025cites this paper
• Efficacy and Safety of Lisdexamfetamine Versus Topiramate Versus Naltrexone/Bupropion in Individuals With Binge Eating Disorder: A Network Meta‐Analysis

  2025cites this paper
• An Efficient Combination Therapy with Lisdexamfetamine Dimesylate and Topiramate in Improving Binge Eating Scale & Metabolic Profile in Binge Eating Disorder: A Randomized Control Trial

  2024cites this paper
• Pharmacological Studies in Eating Disorders: A Historical Review

  2024cites this paper
• Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases

  2024cites this paper
• Practice Assessment Tool for the Care of Patients With Eating Disorders.

  2024cites this paper
• Psychopharmacology of eating disorders: Systematic review and meta-analysis of randomized controlled trials.

  2023cites this paper
• Pharmacotherapy, alternative and adjunctive therapies for eating disorders: findings from a rapid review

  2023influential citation
• World Federation of Societies of Biological Psychiatry (WFSBP) guidelines update 2023 on the pharmacological treatment of eating disorders

  2023cites this paper
• An exploratory machine learning approach to identify placebo responders in pharmacological binge eating disorder trials

  2022cites this paper
• The effects of lisdexamfetamine dimesylate on eating behaviour and homeostatic, reward and cognitive processes in women with binge-eating symptoms: an experimental medicine study

  2022influential citation
• A literature review of dopamine in binge eating

  2022influential citation
• Screening for Eating Disorders in Adolescents and Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.

  2022cites this paper
• The potential role of stimulants in treating eating disorders.

  2021cites this paper
• Eating Disorders (Anorexia Nervosa and Bulimia Nervosa, Binge Eating Disorder)

  2021cites this paper
• Lisdexamfetamine and binge-eating disorder: A systematic review and meta-analysis of the preclinical and clinical data with a focus on mechanism of drug action in treating the disorder.

  2021cites this paper
• Meta-analysis on the long-term effectiveness of psychological and medical treatments for binge-eating disorder.

  2020cites this paper
• A double-blind, placebo-controlled study of vortioxetine in the treatment of binge-eating disorder.

  2019cites this paper
• A randomized, placebo-controlled crossover trial of phentermine-topiramate ER in patients with binge-eating disorder and bulimia nervosa.

  2019cites this paper
• Lisdexamfetamine: chemistry, pharmacodynamics, pharmacokinetics, and clinical efficacy, safety, and tolerability in the treatment of binge eating disorder

  2018cites this paper
• Normalizing the Neural Correlates of Binge-Eating Disorder with Lisdexamfetamine: A Case Report and Literature Review

  2018cites this paper
• Psychological, pharmacological, and combined treatments for binge eating disorder: a systematic review and meta-analysis

  2018cites this paper
• Pharmacotherapy of eating disorders

  2017cites this paper
• Editorial: New Horizons in the Classification, Biology and Management of Eating Disorders.

  2017cites this paper
• Aggressive clinical approach to obesity improves metabolic and clinical outcomes and can prevent bariatric surgery: a single center experience

  2017influential citation
• CURRENTOPINION Pharmacotherapy of eating disorders

  2017cites this paper